Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,025.00    0.00 (0.00%)
Bid:
6,020.00
Ask:
6,025.00
Spread: 5.00 (0.083%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 8.3 - DCC plc

1 Jun 2026 11:56

Norges Bank - Form 8.3 - DCC plc

Norges Bank - Form 8.3 - DCC plc

PR Newswire

LONDON, United Kingdom, June 01

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.   KEY INFORMATION

 

(a)   Full name of discloser

Norges Bank

(b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c)   Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

DCC plc

 

(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

N/A

(e)   Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

29/05/2026

(f)   In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2.   INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

€0.25 Ordinary Shares

 

Interests

Short positions

Number

%

Number

%

(1)   Relevant securities owned and/or controlled

1,454,629

1.70

 

 

(2)   Cash-settled derivatives

 

 

 

 

(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

1,454,629

1.70

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3.   DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)   Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit (Note 5)

€0.25 Ordinary Shares

Purchase

7,278

GBP 60.0500

Ap29

 

(b)   Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

 

 

 

 

 

(c)   Stock-settled derivative transactions (including options)

(i)   Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit

   

 

 

 

 

 

 

 

(ii)   Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

 

(d)   Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

Ap30

 

4.   OTHER INFORMATION

 

(a)   Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

(b)   Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

(c)   Attachments

 

Is a Supplemental Form 8 attached?

NO

 

Date of disclosure

01/06/2026

Contact name

Stanislav Boiadjiev

Telephone number

+4724073000

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 



Date   Source Headline
19th Nov 202510:16 amRNSHolding in Company TR-1
18th Nov 20256:05 pmRNSHolding in Company TR-1
17th Nov 20257:00 amRNSProposed return of up to £600m by tender offer
13th Nov 20255:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSResults for the six months ended 30 September 2025
3rd Nov 20257:00 amRNSCompletion of sale of Info Tech business
21st Oct 202512:30 pmRNSLiquid Gas Acquisitions
17th Oct 20259:50 amRNSHolding in Company TR-1
17th Oct 20257:00 amRNSDirector Declaration
15th Oct 20253:38 pmRNSHolding in Company TR-1
13th Oct 202512:45 pmRNSHolding in Company TR-1
7th Oct 20252:00 pmRNSHolding in Company TR-1
3rd Oct 20254:30 pmRNSHolding in Company TR-1
1st Oct 202512:43 pmRNSHolding in Company TR-1
25th Sep 20254:02 pmRNSHolding in Company TR-1
22nd Sep 20256:09 pmRNSHolding in Company TR-1
22nd Sep 202511:20 amRNSHolding in Company TR-1
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSDCC Healthcare sale completes and capital return
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:56 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20256:11 pmRNSHigh Court Approval of Reduction of Capital
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.